Literature DB >> 23726863

Brain metabolism in patients with hepatic encephalopathy studied by PET and MR.

Susanne Keiding1, Nicola Pavese.   

Abstract

We review PET- and MR studies on hepatic encephalopathy (HE) metabolism in human subjects from the point of views of methods, methodological assumptions and use in studies of cirrhotic patients with clinically overt HE, cirrhotic patients with minimal HE, cirrhotic patients with no history of HE and healthy subjects. Key results are: (1) Cerebral oxygen uptake and blood flow are reduced to 2/3 in cirrhotic patients with clinically overt HE but not in cirrhotic patients with minimal HE or no HE compared to healthy subjects. (2) Cerebral ammonia metabolism is enhanced due to increased blood ammonia in cirrhotic patients but the kinetics of cerebral ammonia uptake and metabolism is not affected by hyperammonemia. (3) Recent advantages in MR demonstrate low-grade cerebral oedema not only in astrocytes but also in the white matter in cirrhotic patients with HE.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain oedema; Cerebral ammonia metabolism; Cerebral blood flow; Cerebral oxygen metabolism; Hyperammonemia

Mesh:

Substances:

Year:  2013        PMID: 23726863     DOI: 10.1016/j.abb.2013.05.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Organ Distribution of 13N Following Intravenous Injection of [13N]Ammonia into Portacaval-Shunted Rats.

Authors:  Nancy F Cruz; Gerald A Dienel; Patricia A Patrick; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

2.  Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Authors:  Vishwadeep Ahluwalia; Douglas M Heuman; George Feldman; James B Wade; Leroy R Thacker; Edith Gavis; HoChong Gilles; Ariel Unser; Melanie B White; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2014-08-08       Impact factor: 25.083

Review 3.  α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.

Authors:  Arthur J L Cooper; Tomiko Kuhara
Journal:  Metab Brain Dis       Date:  2013-11-14       Impact factor: 3.584

Review 4.  Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.

Authors:  Leif Hertz; Dan Song; Liang Peng; Ye Chen
Journal:  Neurochem Res       Date:  2016-06-10       Impact factor: 3.996

5.  Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease.

Authors:  Veronika Rackayová; Emmanuelle Flatt; Olivier Braissant; Jocelyn Grosse; Daniela Capobianco; Paola Mastromarino; Matthew McMillin; Sharon DeMorrow; Valérie A McLin; Cristina Cudalbu
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

6.  Thalamic Structural Connectivity Abnormalities in Minimal Hepatic Encephalopathy.

Authors:  Hua-Jun Chen; Xiao-Hong Zhang; Jia-Yan Shi; Shao-Fan Jiang; Yi-Fan Sun; Ling Zhang; Dan Li; Rong Chen
Journal:  Front Neuroanat       Date:  2021-02-25       Impact factor: 3.856

Review 7.  Quantitative analysis of neurotransmitter pathways under steady state conditions - a perspective.

Authors:  Arthur J L Cooper
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-18       Impact factor: 5.555

8.  Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease.

Authors:  Veronika Rackayova; Olivier Braissant; Anne-Laure Rougemont; Cristina Cudalbu; Valérie A McLin
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.